<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="vaccines-07-00053-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">vaccines-07-00053-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Summary of novel influenza virus vaccine platforms.</p>
 </caption>
 <table frame="hsides" rules="rows">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccines</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Design</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Virus-like particle vaccines (VLP)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Self-assembling viral matrices that express a single or multivalent viral surface proteins</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B36-vaccines-07-00053" ref-type="bibr">36</xref>,
     <xref rid="B37-vaccines-07-00053" ref-type="bibr">37</xref>,
     <xref rid="B38-vaccines-07-00053" ref-type="bibr">38</xref>,
     <xref rid="B39-vaccines-07-00053" ref-type="bibr">39</xref>,
     <xref rid="B40-vaccines-07-00053" ref-type="bibr">40</xref>,
     <xref rid="B41-vaccines-07-00053" ref-type="bibr">41</xref>,
     <xref rid="B42-vaccines-07-00053" ref-type="bibr">42</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Computationally optimized broadly reactive antigen vaccines (COBRA)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">VLPs bearing computationally optimized viral surface proteins</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B43-vaccines-07-00053" ref-type="bibr">43</xref>,
     <xref rid="B44-vaccines-07-00053" ref-type="bibr">44</xref>,
     <xref rid="B45-vaccines-07-00053" ref-type="bibr">45</xref>,
     <xref rid="B46-vaccines-07-00053" ref-type="bibr">46</xref>,
     <xref rid="B47-vaccines-07-00053" ref-type="bibr">47</xref>,
     <xref rid="B48-vaccines-07-00053" ref-type="bibr">48</xref>,
     <xref rid="B49-vaccines-07-00053" ref-type="bibr">49</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Synthetic virus</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Generation of replication-incompetent viruses bearing genetically attenuated genomic sequences</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B18-vaccines-07-00053" ref-type="bibr">18</xref>,
     <xref rid="B49-vaccines-07-00053" ref-type="bibr">49</xref>,
     <xref rid="B50-vaccines-07-00053" ref-type="bibr">50</xref>,
     <xref rid="B51-vaccines-07-00053" ref-type="bibr">51</xref>,
     <xref rid="B52-vaccines-07-00053" ref-type="bibr">52</xref>,
     <xref rid="B53-vaccines-07-00053" ref-type="bibr">53</xref>,
     <xref rid="B54-vaccines-07-00053" ref-type="bibr">54</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Epitope</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Epitope-rich proteins of viruses, designed to induce protective epitope targeted antibodies</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B55-vaccines-07-00053" ref-type="bibr">55</xref>,
     <xref rid="B56-vaccines-07-00053" ref-type="bibr">56</xref>,
     <xref rid="B57-vaccines-07-00053" ref-type="bibr">57</xref>,
     <xref rid="B58-vaccines-07-00053" ref-type="bibr">58</xref>,
     <xref rid="B59-vaccines-07-00053" ref-type="bibr">59</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">antigen-presenting cell (APC) inducible</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">APC-targeted delivery of immunogenic viral proteins to induce quicker and T cell responses</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B60-vaccines-07-00053" ref-type="bibr">60</xref>,
     <xref rid="B61-vaccines-07-00053" ref-type="bibr">61</xref>,
     <xref rid="B62-vaccines-07-00053" ref-type="bibr">62</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Nanoparticle-based</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Self-assembling nano-molecules that carry a single or multivalent viral surface protein</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B63-vaccines-07-00053" ref-type="bibr">63</xref>,
     <xref rid="B64-vaccines-07-00053" ref-type="bibr">64</xref>,
     <xref rid="B65-vaccines-07-00053" ref-type="bibr">65</xref>,
     <xref rid="B66-vaccines-07-00053" ref-type="bibr">66</xref>,
     <xref rid="B67-vaccines-07-00053" ref-type="bibr">67</xref>,
     <xref rid="B68-vaccines-07-00053" ref-type="bibr">68</xref>,
     <xref rid="B69-vaccines-07-00053" ref-type="bibr">69</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral-vectored</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mainly involves use of dissimilar viral matrices as carriers of specific viral protein</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B70-vaccines-07-00053" ref-type="bibr">70</xref>,
     <xref rid="B71-vaccines-07-00053" ref-type="bibr">71</xref>,
     <xref rid="B72-vaccines-07-00053" ref-type="bibr">72</xref>,
     <xref rid="B73-vaccines-07-00053" ref-type="bibr">73</xref>,
     <xref rid="B74-vaccines-07-00053" ref-type="bibr">74</xref>,
     <xref rid="B75-vaccines-07-00053" ref-type="bibr">75</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
